Such anti-tumor function of TNFRSF18 may be mediated through the induction of p21 and PUMA, two direct downstream targets of p53, together with modulation of NF-κB in TNFRSF18-overexpressing MM cells75. The gene discussed is NFKB1; the disease is Miyoshi myopathy.